Latest Industry News & Trends
Market Scope provides comprehensive coverage of the ophthalmic market. Our news stories are a combination of public and proprietary content ranging from coverage of international meetings, surgeon survey results and trends, analysis of company financial reports and public medical registries, press releases, and interviews with executives. Register today to receive free weekly email updates, our top data chart, surgeon poll results, and much more. Locked content can be accessed through a subscription to our ophthalmic industry newsletters.
Recently Added News
Annual and Quarterly Ophthalmic Revenue Roundup for Santen, Carl Zeiss Meditec, Harrow, RxSight, ANI, and Lensar
Japan-based Santen reported May 12 that its revenue for its fiscal year 2025, which ended March 31, 2026, was JPY 291.6 billion ($1.8 billion, calculated for March 31, 2026), a 2.8 percent decline ...
Bausch + Lomb Launches PreserVision AREDS3 Eye Vitamins in the US
Bausch + Lomb reported May 19 that it had launched its PreserVision AREDS3 eye vitamins in the US. The supplements add a unique B-vitamin complex to the AREDS2 nutrients recommended by the National...
Myopia Management Roundup: SightGlass, Hoya Tout Positive Results with Spectacle Lenses
SightGlass Vision reported May 6 that its DOT spectacle lenses for myopia control saved more than 1 diopter of progression on average after two years in a study of Chinese children ages 6 to 10. Th...
Portuguese Study of Luxturna Shows Functional Benefits, Structural Decline
Luxturna (voretigene neparvovec) has demonstrated in clinical trials and real-world studies that it improves light sensitivity and functional vision, with a favorable safety profile. A new prospect...
Curative to Advance Metformin Eye Drops in Cooperation with PennVet
Curative Biotechnology announced May 7 that it had entered into a sponsored research agreement with the University of Pennsylvania’s School of Veterinary Medicine (PennVet) to support a canine stud...
AOA Honors Leaders in Optometry With 2026 Annual Awards
The American Optometric Association (AOA), the American Optometric Student Association, and the AOA Foundation have announced the recipients of the organizations’ 2026 annual awards. The winners ar...
2026-2027 Ophthalmic Meetings Calendar
Market Scope regularly updates its list of ophthalmic meetings to keep the information current. Please contact us at matthewdouty@market-scope.com if we do not have your meeting listed. Thank you.
Generics, New Drug Classes, Sustained Release Dosing Shape Glaucoma Pharma Market
The glaucoma pharmaceuticals market is showing signs of emerging from its prolonged revenue slump. One cycle of conversions from proprietary drugs to generic drugs is nearing an end, and a new cycl...
Q1-2026 Ophthalmic Revenue Roundup for Tarsus, Sight Sciences, and Lenz
Tarsus Pharmaceuticals, of Irvine, California, reported May 6 that its Q1-2026 revenue for Xdemvy was $145.4 million, an 85 percent increase over $78.3 million in Q1-2025. Xdemvy (lotilaner ophthal...
US FDA Commissioner Makary Resigns After Rocky Year in Top Job
US FDA Commissioner Marty Makary, MD, MPH, resigned May 12 after a rocky year in the agency’s top job that saw mass layoffs, high-level resignations, and policy fights with lawmakers, drugmakers, a...
AMA Urges Physician Protections Against AI Deepfake Impersonation
The American Medical Association (AMA) in April issued a policy framework that it says aims to combat the escalating risk of AI-manipulated images, videos, and audio that impersonate physicians. Th...
Mexico Approves Zeiss’ Artevo 850 OR Microscope and Micor 700 Cataract Handpiece
Carl Zeiss Meditec announced May 13 that regulators in Mexico had approved the Artevo 850 ophthalmic microscope and the Micor 700 cataract removal handpiece. The German company, with US headquarter...
Past News Stories
IOP-Lowering Goggles Gain US FDA 510(k) Nod for Wireless Upgrade
Balance Ophthalmics announced May 12 that it had gained US FDA 510(k) clearance for a wireless-enabled, next-generation version of its FSYX Ocular Pressure Adjusting Pump (FSYX OPAP) system, design...
NeuroVision Acquires Durin Life Sciences to Advance Neurological Diagnostics
NeuroVision, the developer of Afina retinal imaging technology to detect neurodegenerative disease, announced May 12 that it had acquired Durin Life Sciences, of Stratford, New Jersey. No financial...
2026 ASCRS Meeting Adds Patriotic Pomp, Lighter Features to Program
A wave of IOL launches dominated the 2026 meeting of the American Society of Cataract and Refractive Surgery (ASCRS), highlighting intensifying competition across the premium IOL space. But confere...
IOL Makers Go All in to Launch Premium Lenses at ASCRS Meeting
Johnson & Johnson Vision, BVI Medical, and Alcon showcased the strengths of their latest IOLs throughout the 2026 ASCRS meeting, explaining how their technology benefits the growing premium space. ...
Myopia Management Market Poised for Growth with Recent Product Advancements
Recent moves by eye care companies suggest that the myopia management market is entering a new phase. In September 2025, Essilor gained US marketing authorization for the Stellest, the first specta...
Bayer to Acquire Perfuse in Deal Worth Up to $2.45 Billion
German drugmaker Bayer announced May 6 that it would acquire Perfuse Therapeutics in a deal worth up to $2.45 billion. Perfuse, of South San Francisco, California, is advancing PER-001 for glaucoma...
Revenio Group to Acquire Visionix in $341 Million Deal
Finland’s Revenio Group, parent of ophthalmic diagnostic company iCare, announced April 13 that it would acquire France-based Visionix in a deal worth €290 million ($341 million). Revenio said that...
Select US FDA Approvals and Clearances in April 2026
The US FDA’s ophthalmic device division granted clearance to four devices using the 510(k) pathway in April 2026, according to the agency’s database. Retmap received clearance for its RM Electrode,...
PDUFA Dates for Ophthalmic Drug Candidates
The US FDA has scheduled the following Prescription Drug User Fee Act (PDUFA) target action dates for ophthalmic drug, drug/device, and biologic candidates.
US CMS Issues J-Codes and Q-Codes for Four Ophthalmic Products in Q1-2026
The US Centers for Medicare and Medicaid Services (CMS) issued J-codes in Q1-2026 for Harrow’s Iopidine and Glaukos’ Epioxa and Epioxa HD. In addition, the CMS issued Q-codes for Zydec’s interchang...
Santen to Market Five of AbbVie’s Glaucoma Drops in Mainland China
Japan’s Santen Pharmaceutical announced April 17 that its China subsidiary had entered into a distribution and promotion agreement with AbbVie for five marketed glaucoma eye drops in the Chinese ma...
Viridian Leads Latest Fundraising with $250 Million in Public Offerings
Viridian Therapeutics led recent ophthalmic fundraising efforts with $250 million in public offerings of convertible notes and Series B stock to advance its TED candidates. Financing announced in t...
Want to Read the Full Article?
Already Have an Account?
Register A Corporate Account
A corporate account gives you access to licensed reports and subscriptions, the latest news, a personalized dashboard, and weekly emails with news and data.